Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment

Direct oral anticoagulants (DOACs) are gaining popularity for patients with nonvalvular atrial fibrillation (AF) for stroke prevention. Less bleeding risk with comparable stroke prevention compared to warfarin was shown. DOACs have predictable anticoagulant effects, infrequent monitoring requirement...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Soo Min, Bahjri, Khaled, Tran, Huyentran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151721/
https://www.ncbi.nlm.nih.gov/pubmed/32143504
http://dx.doi.org/10.3390/pharmacy8010030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151721/
https://www.ncbi.nlm.nih.gov/pubmed/32143504
http://dx.doi.org/10.3390/pharmacy8010030

Ejemplares similares